Search Results 231-240 of 16065 for GLP-1 agonist

  1. Renal Intervention For Chronic Hypertension Pilot Trial Using The Verve Medical RPDTM System (RPD Pilot Trial) - Mayo Clinic

    ... one kidney split function less than 35% 11. Polycystic kidney disease. 12. Diabetes treated with SGLT2 inhibitor and/or GLP-1 agonist 13. Persistent ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...

  3. Publications - Tyler S. Oesterle, M.D., M.P.H. - Mayo Clinic

    Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder. Brain Sci. 2025 Jun 29; 15 (7) Epub 2025 June 29. View PubMed ...

  4. Endocrinology Clinical Trials - Medical Professionals

    ... agonist pioglitazone, with or without weight loss ... The purpose of this study is to evaluate whether or not a 6 month supply (1 ... Go to page 11 · Go to page 22 ...

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

    Prior exposure to exenatide or other GLP-1R agonists. Prior exposure to NLY01. Participating Mayo Clinic locations. Study statuses change often. Please ...

  6. Popliteal artery aneurysm - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the ... Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri ...

  7. Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects - Mayo Clinic

    aromatase inhibitors, amiodarone, or long-term use of tetracyclines). - Type 1 diabetes subjects, or T2DM subjects on insulin and/or GLP-1 receptor agonist

  8. Follitropin alfa (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Some patients may be treated with another hormone called gonadotropin-releasing hormone agonist (GnRHa) before starting treatment with follitropin alfa.

  9. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma - Mayo Clinic

    About this study. This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called ...

  10. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

    Receiving a glucagon-like peptide 1 (GLP-1) receptor agonist, a dipeptidyl peptidase 4 (DPP-4) inhibitor, a sodium–glucose cotransporter 2 (SGLT2) and/or ...